Evidence map›Paper›PMID 38188249›Full record

ArticleUpsala journal of medical sciences2023

Dose-dependent regulation of kidney mitochondrial function by angiotensin II.

Ebba Sivertsson, Amanda Balboa, Tomas A Schiffer, Peter Hansell, Malou Friederich-Persson, Patrik Persson, Fredrik Palm

Open access · diamondAbstract read
In one paragraph

Article in Upsala journal of medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Targeting NHypertension (Dallas, Tex. : 1979) · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ebba SivertssonDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Amanda BalboaDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Tomas A SchifferDepartment of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
Peter HansellDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Malou Friederich-PerssonDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Patrik PerssonDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Fredrik PalmDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Uppsala University · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intrarenal hypoxia has been suggested a unifying pathway to chronic kidney disease (CKD) and increased mitochondria leak respiration, which increases mitochondrial oxygen usage and is one important mechanism contributing to the development of the hypoxia. Previous studies indicate that angiotensin II (Ang II) effects on mitochondria function could be dose dependent. We investigated how moderate and high levels of Ang II affect kidney mitochondria function and pathways of leak respiration. Methods: C57 black 6 mice were treated with either vehicle or Ang II in low dose (400 ng/kg/min) or high dose (1,000 ng/kg/min) for 4 weeks. The function of kidney cortex mitochondria was measured by high-resolution respirometry. Ang II effects on gene expression in kidney tissue were measured by quantitative real-time PCR. Thiobarbituric acids reactive substances were determined as a marker of oxidative stress, and urinary protein excretion was measured as a maker of kidney injury. Results: Low-dose Ang II induced overall mitochondria respiration, without compromising capacity of ATP production. Mitochondrial leak respiration was increased, and levels of oxidative stress were unchanged. However, high-dose Ang II decreased overall mitochondria respiration and reduced mitochondrial capacity for ATP production. Mitochondrial leak respiration was decreased, and oxidative stress increased in kidney tissue. Furthermore, gene expression of mediators that stimulate vasoconstriction and ROS production was increased, while components of counteracting pathways were decreased. Conclusions: In conclusion, Ang II dose-dependently affects mitochondrial function and leak respiration. Thus, Ang II has the potential to directly affect cellular metabolism during conditions of altered Ang II signaling.

Indexed as

Angiotensin IIKidneyAdenosine TriphosphateAnimalsHypoxiaMiceMitochondriaAdenosine TriphosphateAngiotensin IIAngiotensin IIkidneymitochondria functionmitochondria leak respirationoxidative stressrenin-angiotensin II-aldosterone systemuncoupling

Identifiers

PMID38188249
PMCPMC10770640
OpenAlexW4390114499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.